These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32588437)

  • 1. Telethonin variants found in Brugada syndrome, J-wave pattern ECG, and ARVC reduce peak Na
    Turker I; Makiyama T; Ueyama T; Shimizu A; Yamakawa M; Chen PS; Vatta M; Horie M; Ai T
    Pacing Clin Electrophysiol; 2020 Aug; 43(8):838-846. PubMed ID: 32588437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
    Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M
    PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
    Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
    Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
    Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
    Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between sodium channel function and clinical phenotype in SCN5A variants associated with Brugada syndrome.
    Pearman CM; Denham NC; Mills RW; Ding WY; Modi SS; Hall MCS; Todd DM; Mahida S
    Hum Mutat; 2020 Dec; 41(12):2195-2204. PubMed ID: 33131149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p.D1690N sodium voltage-gated channel α subunit 5 mutation reduced sodium current density and is associated with Brugada syndrome.
    Zeng Z; Xie Q; Huang Y; Zhao Y; Li W; Huang Z
    Mol Med Rep; 2016 Jun; 13(6):5216-22. PubMed ID: 27108952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
    Zeng Z; Zhou J; Hou Y; Liang X; Zhang Z; Xu X; Xie Q; Li W; Huang Z
    PLoS One; 2013; 8(10):e78382. PubMed ID: 24167619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of the Navβ1b sodium channel subunit in human ventricle; functional characterization of the H162P Brugada syndrome mutant.
    Yuan L; Koivumäki JT; Liang B; Lorentzen LG; Tang C; Andersen MN; Svendsen JH; Tfelt-Hansen J; Maleckar M; Schmitt N; Olesen MS; Jespersen T
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1204-12. PubMed ID: 24561865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the SCN5A gene contributes to arrhythmogenic characteristics of early repolarization syndrome.
    Guo Q; Ren L; Chen X; Hou C; Chu J; Pu J; Zhang S
    Int J Mol Med; 2016 Mar; 37(3):727-33. PubMed ID: 26820605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Analysis of SCN5A Genetic Variants Associated with Brugada Syndrome.
    Mikhailova VB; Karpushev AV; Vavilova VD; Klimenko ES; Tulintseva T; Yudina YS; Vasichkina ES; Zhorov BS; Kostareva A
    Cardiology; 2022; 147(1):35-46. PubMed ID: 34628415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced closed-state inactivation of mutant cardiac sodium channels (SCN5A N1541D and R1632C) through different mechanisms.
    Dharmawan T; Nakajima T; Iizuka T; Tamura S; Matsui H; Kaneko Y; Kurabayashi M
    J Mol Cell Cardiol; 2019 May; 130():88-95. PubMed ID: 30935997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.